1. Home
  2. BQ vs NDRA Comparison

BQ vs NDRA Comparison

Compare BQ & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boqii Holding Limited representing

BQ

Boqii Holding Limited representing

HOLD

Current Price

$0.83

Market Cap

7.7M

ML Signal

HOLD

Logo ENDRA Life Sciences Inc.

NDRA

ENDRA Life Sciences Inc.

N/A

Current Price

$5.75

Market Cap

8.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BQ
NDRA
Founded
2008
2007
Country
China
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.7M
8.1M
IPO Year
2020
2016

Fundamental Metrics

Financial Performance
Metric
BQ
NDRA
Price
$0.83
$5.75
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$30.00
AVG Volume (30 Days)
4.7M
38.4K
Earning Date
01-05-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
84.32
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.65
$2.96
52 Week High
$72.74
$9.83

Technical Indicators

Market Signals
Indicator
BQ
NDRA
Relative Strength Index (RSI) 41.02 58.72
Support Level $0.70 $4.49
Resistance Level $0.89 $6.35
Average True Range (ATR) 0.05 0.69
MACD -0.02 0.10
Stochastic Oscillator 2.11 62.76

Price Performance

Historical Comparison
BQ
NDRA

About BQ Boqii Holding Limited representing

Boqii Holding Ltd is a pet-focused platform in China. It offer a truly one-stop destination that pet parents in China may go to get everything it need for their pets and share their passion for pet parenting. It operate a pet-focused online retail business in China's pet market in terms of GMV. The company operates in single segment. This segment is engaged in pet products sales and online marketing and information services and other. All the company's revenues is derived from The PRC.

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of thermo-acoustic enhanced ultrasound (TAEUS) technology to improve the capabilities of clinical diagnostic ultrasound. The company's technology is used to measure tissue composition, including the assessment of fat in the liver, and is being developed for additional clinical applications such as tissue temperature monitoring.

Share on Social Networks: